Learn more about how our flexible lab space and expert staff can help you meet your diagnostic needs.
Inflammatory bowel disease - Insights
Our robust menu of inflammatory bowel disease (IBD) testing can assist with the diagnosis and management of IBD and includes first-line fecal testing for calprotectin; serologic analysis of clinically relevant antibodies; and genetic...
Mayo Clinic Laboratories’ targeted testing for opioids uses high-resolution mass spectrometry to detect 33 different opioids.
Mayo Clinic Laboratories’ targeted benzodiazepine testing uses high-resolution mass spectrometry to identify 27 different benzodiazepines and metabolites in the urine.
Precision mental and behavioral health therapeutics - Insights
Our Precision Mental and Behavioral Health Therapeutics initiative leverages cutting-edge diagnostic solutions to optimize medication management for psychiatric and neurologic patients.
Emergency toxicology - Insights
Mayo Clinic Laboratories’ emergency toxicology testing can help providers manage overdose by clarifying whether symptoms are due to the presence of drugs.
Find out why testing for anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies is recommended for differential diagnosis.
Head and neck pathology at Mayo Clinic Laboratories
Head and neck pathology consultations often relate to the classification of salivary, sinonasal, and oropharynx tumors.Check out Mayo Clinic Laboratories’ head and neck pathology section, which is integrated with the clinical practice at...
PDL1 Testing for Lung Cancer [A Test in Focus] - Insights
Audio Interview Testing When to Order Specimen Performance Immunotherapies have recently emerged as a therapeutic option for patients with non-small-cell
Myelodysplastic syndrome - Insights
Browse our wide variety of testing options for the prognosis and risk stratification associated with myelodysplastic syndrome.
Additional neuromuscular disorders - Insights
Learn how our comprehensive menu of focused panels can provide clarity and confidence when diagnosing neuromuscular disorders.
See how our Special Coagulation Laboratory offers algorithmic approaches to meet your bleeding disorder testing needs.
Disease-specific panels - Insights
Learn how disease-specific cancer panels help providers understand their patients’ risk of having a hereditary cancer syndrome.
Comprehensive panels - Insights
Learn how our in-depth genetic testing can determine whether a cancer is hereditary in origin for individuals with a family history of cancer.
Find out how patients with a cancer diagnosis can benefit from single-gene analysis to pinpoint whether the cancer is genetic in nature.
Necrotizing Autoimmune Myopathy Testing - Mayo Clinic Laboratories
We offer advanced testing of the most pertinent antibodies associated with IMNM on a sensitive immunofluorescence-based assay providing fast results for patients.
Autoimmune Dementia Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune dementia contains only clinically relevant antibodies providing accurate answers for treatment guidance.
See how our comprehensive fluorescence in situ hybridization panels simplify the ordering process to ensure every patient receives the right test.
Next-generation sequencing - Insights
Learn more about the advantages offered by Mayo Clinic Laboratories’ next-generation sequencing panel for plasma cell neoplasms.
Children's Oncology Group - Insights
Learn how our team’s commitment and large testing menu helps in meeting the specific needs of Children’s Oncology Group patients.
Non-Colorectal GI Tumor Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories offers additional testing for GIST tumors and several other types of non-colorectal GI tumors.
Serotonin release assay - Insights
Find out more about our serotonin release assay, the gold standard diagnostic test for detecting heparin-induced thrombocytopenia antibodies.
Comprehensive neuromuscular panel - Insights
Find out how the emergence of advanced molecular testing technologies has enhanced the detection of inherited neuromuscular disorders.
Learn how our muscular dystrophy genetic testing can help patients access variant-specific therapies and determine eligibility for clinical trials.
Sleep Disorder Testing - Mayo Clinic Laboratories
Determining orexin-A/ hypocretin-1 levels through CSF testing provides a sensitive and specific result to guide appropriate treatment for patients.
Hereditary hearing loss - Insights
Learn how our hereditary hearing loss test can help avoid unnecessary workups and appointments and reduce anxiety for patients and their families.
Amyloidosis Testing - Mayo Clinic Laboratories
Mayo Clinic’s amyloid protein identification methodology is considered the gold standard because of the high sensitivity and accuracy with which it types amyloid proteins in paraffin-embedded specimens.
Necrotizing Autoimmune Myopathy [Test in Focus] - Insights
Necrotizing autoimmune myopathy (NAM) is a serious but rare muscle disease strongly associated with autoantibodies to either the protein signal recognition particle (SRP) or the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase...
Mayo Clinic Laboratory and pathology research roundup: April 19 - Insights
Top highlights include: Advances in neuroimaging for brain charts for the human lifespan.
Labor Day Specimen Shipment Alert - Insights
Due to the Labor Day holiday (recognized on Monday, September 5th), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, plan ahead.
Labor Day specimen shipment alert - Insights
Due to the Labor Day holiday (recognized on Monday, September 6), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered.
Should You Worry if You Accidentally Swallow an Insect? - Insights
During summer activities, it's bound to happen. But how dangerous is it to accidentally swallow a bug? Bobbi Pritt, M.D., a microbiologist, pathologist, and Director of the Clinical Parasitology Laboratory at Mayo Clinic in Rochester,...
The Right Medication for You: Pharmacogenomics Testing at Mayo Clinic - Insights
How Your Genes Determine which Medications Work Best for You The drugs available today to treat diseases are powerful agents that work as intended for
Blood Diversion/Culture Contamination - Insights
PACE / State of FLThis “phlebotomy webinar” will address the evidence behind blood diversion as a mechanism to lower blood culture contamination rates and discuss the experience at Mayo Clinic Rochester with a pilot of one blood diversion...
Hepatitis C Virus Genotypic Antiviral Drug Resistance [Test in Focus] - Insights
Joseph Yao, M.D., gives an overview of this new test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon other testing approaches, and what clinical action can be...
CPT codes and LOINC update: August 2022 - Insights
This list includes updates posted to mayocliniclabs.com during the month of August.
Pediatric CNS Disorder Evaluations [Test in Focus] - Insights
Autoimmune encephalitis and myelitis is increasingly recognized as a cause of CNS disease in children and teens. Andrew McKeon, M.B., B.Ch., M.D, gives an overview of this test available through Mayo Clinic Laboratories. He discusses when...
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
The standard test for the diagnosis of narcolepsy is the multiple sleep latency test (MSLT). The MSLT is a complex test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT...
Copeptin [Test in Focus] - Insights
Joshua Bornhorst, Ph.D., gives an overview of the new Copeptin test available through Mayo Clinic Laboratories. He discusses when this testing should be ordered, how this testing improves upon previous testing approaches, and what clinical...
Testing to Identify Clinically Significant Chromosomal Abnormalities - Insights
This week's featured chromosomal microarray test in focus is presented by William Sukov, M.D., a pathologist and cancer geneticist at Mayo Clinic. He discusses when this test should be used for patients with renal tumors.
On the Sept. 2 broadcast of Mayo Clinic Radio, co-hosts Tracy McCray and Tom Shives, M.D., spoke with Justin Kreuter, M.D., Medical Director of Mayo’s Blood Donor Program, about new eligibility guidelines for blood donors with previous...
Week in Review: October 25 - Insights
Top highlights include: a new high-tech product may pose a threat to the classic stethoscope, bedtime might be the best time for blood pressure medications, food can help control chronic health conditions, and you may have had a silent...
Perspectives Archives - Page 9 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Culturally Sensitive and Medically Appropriate Care for Transgender Patients Sketchnote - Insights
In this sketchnote, Caroline Davidge-Pitts, M.B., B.Ch., and Todd Nippoldt, M.D., share inclusive terminology and lessons learned from Mayo Clinic’s Transgender Intersex Specialty Care Clinic.
Tick Dragging with Bobbi Pritt, M.D. - Insights
On a recent tick drag with Minnesota Department of Health researchers, Bobbi Pritt, M.D., Director of the Clinical Parasitology Lab and Co-Director of Vector-Borne Diseases Lab Services in Mayo Clinic’s Department of Lab Medicine and...
Mayo Clinic Laboratory and Pathology Research Roundup: July 9 - Insights
This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.
Dr. Pandey is a nuclear radiology researcher working with a team to develop a new radioactive tracer to detect prostate cancer.
Mayo Clinic Laboratory and Pathology Research Roundup: May 21 - Insights
This week’s Research Roundup highlights the development and validation of a prostate cancer genomic signature that predicts early androgen deprivation therapy (ADT) treatment response following radical prostatectomy.
Graduation Is upon Us - Insights
Elizabeth Gamache, a student in Mayo Clinic’s Medical Laboratory Science class of 2018, discusses the 2018's class impending graduation and what they have to look forward to afterward.
Staffing to Workload in Phlebotomy Areas: On-Site Operational Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on "on-site operational needs," which is defined as "staff effort that does not deal directly with patients or their...